Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course
Background. Imatinib mesylate is the gold standard for the treatment of all phases of
Philadelphia‐positive chronic myeloid leukemia. Patients on imatinib treatment may develop …
Philadelphia‐positive chronic myeloid leukemia. Patients on imatinib treatment may develop …
Ctopenia Following Imatinib Treatment of Chronic Myeloid Leukemia (Cml) in Kenya: a Study at Gipap Clinic, Nairobi Hospital
AA Mcligeyo - 2018 - erepository.uonbi.ac.ke
Background: Imatinib mesylate is the preferred initial treatment for all phases of Philadelphia
positive CML. During treatment, patients may develop cytopenia, namely anemia …
positive CML. During treatment, patients may develop cytopenia, namely anemia …
[PDF][PDF] Research Article Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course
Background. Imatinib mesylate is the gold standard for the treatment of all phases of
Philadelphia-positive chronic myeloid leukemia. Patients on imatinib treatment may develop …
Philadelphia-positive chronic myeloid leukemia. Patients on imatinib treatment may develop …
Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course.
Background: Imatinib mesylate is the gold standard for the treatment of all phases of
Philadelphia-positive chronic myeloid leukemia. Patients on imatinib treatment may develop …
Philadelphia-positive chronic myeloid leukemia. Patients on imatinib treatment may develop …